Citation Impact
Citing Papers
The Endogenous Tryptophan Metabolite and NAD+ Precursor Quinolinic Acid Confers Resistance of Gliomas to Oxidative Stress
2013
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
Normal gut microbiota modulates brain development and behavior
2011 Standout
Plasma β-amyloid in Alzheimer’s disease and vascular disease
2016 StandoutNobel
High field MRI in the diagnosis of multiple sclerosis: high field–high yield?
2009
Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial
2010 Standout
Trace derivatives of kynurenine potently activate the aryl hydrocarbon receptor (AHR)
2017
Metabolic dysregulation in vitamin E and carnitine shuttle energy mechanisms associate with human frailty
2019
Depression
2018 Standout
Structural and mechanistic basis of differentiated inhibitors of the acute pancreatitis target kynurenine-3-monooxygenase
2017
Reduced maternal expression of adrenomedullin disrupts fertility, placentation, and fetal growth in mice
2006 StandoutNobel
A randomized trial of carotid artery stenting with and without cerebral protection
2008
The Nonpeptide Calcitonin Gene-Related Peptide Receptor Antagonist BIBN4096BS Lowers the Activity of Neurons with Meningeal Input in the Rat Spinal Trigeminal Nucleus
2005
Kynurenines in the mammalian brain: when physiology meets pathology
2012
High-Throughput Fluorescence-Based Screening Assays for Tryptophan-Catabolizing Enzymes
2014
The microbiota and the gut-brain axis: insights from the temporal and spatial mucosal alterations during colonisation of the germfree mouse intestine
2012
Delayed inflammation in rat meninges: implications for migraine pathophysiology
2001
Association Between Opioid Prescribing Patterns and Opioid Overdose-Related Deaths
2011 Standout
Increased serum kynurenine/tryptophan ratio correlates with disease progression in lung cancer
2009
Altered processing of sensory stimuli in patients with migraine
2014
Neurobiology of migraine
2003
Kynurenic acid and psychotic symptoms and personality traits in twins with psychiatric morbidity
2016
Serotonin inhibits trigeminal nucleus activity evoked by craniovascular stimulation through a 5ht 1b/1D receptor: A central action in migraine?
1998
Huntington's disease
2007 Standout
Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study
2007
Mechanisms involved in the cerebrovascular dilator effects of cortical spreading depression
2008
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
2011 StandoutNature
Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: Comorbidity between depression and neurodegenerative disorders
2008
Hallmarks of aging: An expanding universe
2023 Standout
A role for mitochondria in NLRP3 inflammasome activation
2010 StandoutNature
Animal models of migraine: looking at the component parts of a complex disorder
2006
Localization of CGRP, CGRP receptor, PACAP and glutamate in trigeminal ganglion. Relation to the blood–brain barrier
2014
Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases
2016
The changing landscape of atherosclerosis
2021 StandoutNature
CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-α: relationship to CNS immune responses and depression
2009
Cinnabarinic acid, an endogenous agonist of type-4 metabotropic glutamate receptor, suppresses experimental autoimmune encephalomyelitis in mice
2014
Cognitive impairment in multiple sclerosis
2008 Standout
Design, synthesis and SAR studies of GABA uptake inhibitors derived from 2-substituted pyrrolidine-2-yl-acetic acids
2015
The prevalence of multiple sclerosis in the world: an update
2001
Activation of the kynurenine pathway and increased production of the excitotoxin quinolinic acid following traumatic brain injury in humans
2015
Understanding the role of tryptophan and serotonin metabolism in gastrointestinal function
2009
The probiotic Bifidobacteria infantis: An assessment of potential antidepressant properties in the rat
2008
A Critical Role of Toll-like Receptor 2 in Nerve Injury-induced Spinal Cord Glial Cell Activation and Pain Hypersensitivity
2007
Pituitary adenylate cyclase-activating polypeptide plays a key role in nitroglycerol-induced trigeminovascular activation in mice
2011
Impact of the Gut Microbiota on Intestinal Immunity Mediated by Tryptophan Metabolism
2018
Nature and cause of mitochondrial dysfunction in Huntington’s disease: focusing on huntingtin and the striatum
2010
Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin Biosynthesis
2015 Standout
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
No association between APOE epsilon 4 allele and multiple sclerosis susceptibility: A meta-analysis from 5472 cases and 4727 controls
2011
Multiple sclerosis
2008 Standout
Inflammation and depression: a causal or coincidental link to the pathophysiology?
2017
Principal components analysis corrects for stratification in genome-wide association studies
2006 Standout
Glutamate neurotoxicity and diseases of the nervous system
1988 Standout
Calcitonin Gene–Related Peptide Receptor Antagonist BIBN 4096 BS for the Acute Treatment of Migraine
2004 Standout
Efficacy of the non-peptide CGRP receptor antagonist BIBN4096BS in blocking CGRP-induced dilations in human and bovine cerebral arteries: potential implications in acute migraine treatment
2002
An expanding range of targets for kynurenine metabolites of tryptophan
2012
Association of a polymorphism in the indoleamine- 2,3-dioxygenase gene and interferon-α-induced depression in patients with chronic hepatitis C
2011
Exposure to Kynurenic Acid during Adolescence Increases Sign-Tracking and Impairs Long-Term Potentiation in Adulthood
2015
Apoptosis in Huntington's disease
2003
Parkinson's disease
2015 Standout
Development, maintenance and disruption of the blood-brain barrier
2013 Standout
Glial and neuronal control of brain blood flow
2010 StandoutNature
Demyelination: The Role of Reactive Oxygen and Nitrogen Species
1999
Power failure: why small sample size undermines the reliability of neuroscience
2013 Standout
Early kynurenine pathway activation following cardiac arrest in rats, pigs, and humans
2013
Brown adipose tissue thermogenic adaptation requires Nrf1-mediated proteasomal activity
2018 StandoutNobel
The Kynurenine Pathway Modulates Neurodegeneration in a Drosophila Model of Huntington's Disease
2011
Tryptophan metabolism in the central nervous system: medical implications
2006
Genetics of primary progressive multiple sclerosis
2014
Radical changes in multiple sclerosis pathogenesis
2010
Effect of modulating the allosteric sites of N-methyl-D-aspartate receptors in ischemia-reperfusion induced acute kidney injury
2013
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
2011 Standout
Messenger molecules and receptor mRNA in the human trigeminal ganglion
1999
Cellular and Molecular Mechanisms of Pain
2009 StandoutNobel
GPCR modulation by RAMPs
2005
Tryptophan degradation in autoimmune diseases
2007
Microbiota Modulate Behavioral and Physiological Abnormalities Associated with Neurodevelopmental Disorders
2013 Standout
The role of brain somatostatin receptor 2 in the regulation of feeding and drinking behavior
2015
Structural Basis for Inhibitor-Induced Hydrogen Peroxide Production by Kynurenine 3-Monooxygenase
2018
Kynurenine pathway metabolism and the microbiota-gut-brain axis
2016
The pharmacology of CGRP-responsive receptors in cultured and transfected cells
2004
Adrenomedullin receptors: pharmacological features and possible pathophysiological roles
2004
Serotonin, tryptophan metabolism and the brain-gut-microbiome axis
2014 Standout
Moderate and severe traumatic brain injury in adults
2008 Standout
Kynurenines, Gender and Neuroinflammation; Showcase Schizophrenia
2016
The new ‘5-HT’ hypothesis of depression: Cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression
2010
Amyloid biomarkers in Alzheimer's disease
2015
Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
2019 Standout
The interplay between cytokines and the Kynurenine pathway in inflammation and atherosclerosis
2017
Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues
1992
Serotonin Function and the Mechanism of Antidepressant Action
1990
Kynurenine-3-monooxygenase: a review of structure, mechanism, and inhibitors
2015
Indoleamine-2,3-dioxygenase(IDO)2 polymorphisms are not associated with multiple sclerosis in Italians
2017
EGLN1 Inhibition and Rerouting of α-Ketoglutarate Suffice for Remote Ischemic Protection
2016 StandoutNobel
The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease
2011
Receptor Activity-modifying Proteins 2 and 3 Have Distinct Physiological Functions from Embryogenesis to Old Age
2007 StandoutNobel
Carbonic anhydrase activators: Kinetic and X-ray crystallographic study for the interaction of d- and l-tryptophan with the mammalian isoforms I–XIV
2008
Biomarkers in multiple sclerosis
2015
Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice
2008
Tryptophan 2,3-dioxygenase and indoleamine 2,3-dioxygenase 1 make separate, tissue-specific contributions to basal and inflammation-induced kynurenine pathway metabolism in mice
2016
Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial
2016
Targeting metabolic inflammation in Parkinson’s disease: Implications for prospective therapeutic strategies
2011
Mouse chronic social stress increases blood and brain kynurenine pathway activity and fear behaviour: Both effects are reversed by inhibition of indoleamine 2,3-dioxygenase
2015
TRPV1 and TRPA1 Mediate Peripheral Nitric Oxide-Induced Nociception in Mice
2009 StandoutNobel
Iron Catalysis in Organic Synthesis
2015 Standout
Chemical Inhibition of Kynureninase Reduces Pseudomonas aeruginosa Quorum Sensing and Virulence Factor Expression
2016
Catalytic Asymmetric Additions of Enol Silanes to In Situ Generated Cyclic, AliphaticN‐Acyliminium Ions
2021 StandoutNobel
Neuronal PAC1receptors mediate delayed activation and sensitization of trigeminocervical neurons: Relevance to migraine
2015
Huntington?s disease: pathomechanism and therapeutic perspectives
2004
Immunohistochemical Localization of Calcitonin Receptor–Like Receptor and Receptor Activity–Modifying Proteins in the Human Cerebral Vasculature
2002
Development of a practical and sustainable strategy for the synthesis of ST1535 by an iron-catalyzed Kumada cross-coupling reaction
2014
Kynurenines: Tryptophan’s metabolites in exercise, inflammation, and mental health
2017 Science
Immunohistochemical characterization of calcitonin gene-related peptide in the trigeminal system of the familial hemiplegic migraine 1 knock-in mouse
2011
Role of indoleamine 2,3-dioxygenase in health and disease
2015
Pituitary adenylate cyclase activating polypeptide and migraine
2014
Neurogenetic Adaptive Mechanisms in Alcoholism
1987 StandoutScience
Assessing mitochondrial dysfunction in cells
2011 Standout
Facilitation of memory consolidation by vasopressin: Mediation by terminals of the dorsal noradrenergic bundle?
1979
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
2019 Standout
Adrenomedullin gene expression differences in mice do not affect blood pressure but modulate hypertension-induced pathology in males
2007 StandoutNobel
Central Nervous System Infection with Borna Disease Virus Causes Kynurenine Pathway Dysregulation and Neurotoxic Quinolinic Acid Production
2017
The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease
2011
Review of teriflunomide and its potential in the treatment of multiple sclerosis
2009
Calcitonin Gene-Related Peptide Receptor Inhibition Reduces Neuronal Activity Induced by Prolonged Increase in Nitric Oxide in the Rat Spinal Trigeminal Nucleus
2008
Cloning and functional expression of cDNAs encoding human and rat pancreatic polypeptide receptors.
1996 StandoutNobel
Multiple Sclerosis
2018 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Marked decrease of neuropeptide Y Y2 receptor binding sites in the hippocampus in murine prion disease
1997 StandoutNobel
Kynurenine Aminotransferase Isozyme Inhibitors: A Review
2016
Association of Increased Treg Cell Levels With Elevated Indoleamine 2,3‐Dioxygenase Activity and an Imbalanced Kynurenine Pathway in Interferon‐Positive Primary Sjögren's Syndrome
2016
Investigation of the pathophysiological mechanisms of migraine attacks induced by pituitary adenylate cyclase-activating polypeptide-38
2014
NXN-188, a selective nNOS inhibitor and a 5-HT1B/1D receptor agonist, inhibits CGRP release in preclinical migraine models
2012
How neuroinflammation contributes to neurodegeneration
2016 StandoutScience
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes (II)
2018 Standout
The Janus-Faced Nature of Ido1 in Infectious Diseases: Challenges and Therapeutic Opportunities
2015
Linkage disequilibrium screening for multiple sclerosis implicates JAG1 and POU2AF1 as susceptibility genes in Europeans
2006
CGRP Release and c-fos Expression within Trigeminal Nucleus Caudalis of the Rat following Glyceryltrinitrate Infusion
2005
Glyceryl trinitrate triggers premonitory symptoms in migraineurs
2004
Plasma tau in Alzheimer disease
2016 StandoutNobel
Biphasic Response to Nitric Oxide of Spinal Trigeminal Neurons With Meningeal Input in Rat–Possible Implications for the Pathophysiology of Headaches
2004
Host-Gut Microbiota Metabolic Interactions
2012 StandoutScience
Xanthurenic acid is localized in neurons in the central nervous system
2016
Lactobacillus johnsonii inhibits indoleamine 2,3‐dioxygenase and alters tryptophan metabolite levels in BioBreeding rats
2013
Metabolomics for Investigating Physiological and Pathophysiological Processes
2019
Tryptophan-2,3-dioxygenase (TDO) inhibition ameliorates neurodegeneration by modulation of kynurenine pathway metabolites
2016
Dynamic changes in thalamic microstructure of migraine without aura patients: a diffusion tensor magnetic resonance imaging study
2013
Evidence for brain morphometric changes during the migraine cycle: A magnetic resonance-based morphometry study
2014
Tryptophan metabolism, from nutrition to potential therapeutic applications
2010
Neuropeptide Expression in the Human Trigeminal Nucleus Caudalis and in the Cervical Spinal Cord C1 and C2
2002
Selenium‐Based Nanozyme as Biomimetic Antioxidant Machinery
2018
Kynurenic Acid in the Digestive System–-New Facts, New Challenges
2013
Impact of Plasma Kynurenine Level on Functional Capacity and Outcome in Heart Failure ― Results From Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF) ―
2016
Physiology of Microglia
2011 Standout
Expression of the Transient Receptor Potential Channels TRPV1, TRPA1 and TRPM8 in Mouse Trigeminal Primary Afferent Neurons Innervating the Dura
2012
MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights
2021 Standout
Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?
2012 Standout
Association of amine biomarkers with incident dementia and Alzheimer's disease in the Framingham Study
2017
Works of László Vécsei being referenced
Brain Aging and Disorders of the Central Nervous System: Kynurenines and Drug Metabolism
2016
Kynurenine in combination with probenecid mitigates the stimulation-induced increase of c-fos immunoreactivity of the rat caudal trigeminal nucleus in an experimental migraine model
2006
Kynurenine metabolism in plasma and in red blood cells in Parkinson's disease
2005
Post-ischemic treatment with L-kynurenine sulfate exacerbates neuronal damage after transient middle cerebral artery occlusion
2013
Novel therapy in Parkinson's disease: adenosine A2Areceptor antagonists
2011
Perceptual Categorization Is Impaired in Huntington’s Disease: An Electrophysiological Study
2003
Effect of systemic nitroglycerin on CGRP and 5‐HT afferents to rat caudal spinal trigeminal nucleus and its modulation by estrogen
2002
Effects of somatostatin-28 and some of its fragments and analogs on open-field behavior, barrel rotation, and shuttle box learning in rats
1990
Pharmacological Therapy in Parkinson's Disease: Focus on Neuroprotection
2010
The prealence of multiple sclerosis in the Hungarian city of Szeged
1998
The epidemiology of multiple sclerosis in Europe
2006
Systemic nitroglycerin increases nNOS levels in rat trigeminal nucleus caudalis
2000
Kynurenic acid inhibits intestinal hypermotility and xanthine oxidase activity during experimental colon obstruction in dogs
2007
Different inhibitory effects of kynurenic acid and a novel kynurenic acid analogue on tumour necrosis factor-α (TNF-α) production by mononuclear cells, HMGB1 production by monocytes and HNP1-3 secretion by neutrophils
2011
White matter microstructural alterations in migraine: A diffusion-weighted MRI study
2012
Dementia, stroke and migraine — Some common pathological mechanisms
2010
Effect of a nitric oxide donor on nitroxergic nerve fibers in the rat dura mater
1999
Kynurenines, Parkinson’s disease and other neurodegenerative disorders: preclinical and clinical studies
2006
Modulatory effects of probenecid on the nitroglycerin-induced changes in the rat caudal trigeminal nucleus
2009
Neuroprotective effects of a novel kynurenic acid analogue in a transgenic mouse model of Huntington’s disease
2010
EFNS guideline on mild traumatic brain injury: report of an EFNS task force
2002
The involvement of catecholaminergic mechanisms in the behavioural action of vasopressin
1977
Clinical Efficacy of a Single Afternoon Dose of Effervescent Levodopa-Carbidopa Preparation (CHF 1512) in Fluctuating Parkinson Disease
2007
Endogenous neuroprotection in chronic neurodegenerative disorders: with particular regard to the kynurenines
2010
Mitochondrial disturbances, excitotoxicity, neuroinflammation and kynurenines: Novel therapeutic strategies for neurodegenerative disorders
2012
Evidence-based pharmacological treatment of neuropathic pain syndromes
2005
Electrical stimulation of the Gasserian ganglion induces structural alterations of calcitonin gene-related peptide-immunoreactive perivascular sensory nerve terminals in the rat cerebral dura mater: a possible model of migraine headache
1995
Neuroprotective effect of L-kynurenine sulfate administered before focal cerebral ischemia in mice and global cerebral ischemia in gerbils
2007
Tumour necrosis factor alpha gene (TNF-α) −376 polymorphism in Hungarian patients with primary progressive multiple sclerosis
2009
APOE epsilon status in Hungarian patients with primary progressive multiple sclerosis
2010
Comparative behavioral and neurochemical studies with striatal kainic acid- or quinolinic acid-lesioned rats
1991
Effects of eletriptan on the peptidergic innervation of the cerebral dura mater and trigeminal ganglion, and on the expression of c‐fos and c‐jun in the trigeminal complex of the rat in an experimental migraine model
2000
Kynurenines in chronic neurodegenerative disorders: future therapeutic strategies
2009
Opposite effects of centrally administered neuropeptide Y (NPY) on locomotor activity of spontaneously hypertensive (SH) and normal rats
1989
Depletion of calcitonin gene-related peptide from the caudal trigeminal nucleus of the rat after electrical stimulation of the Gasserian ganglion
1998
Comparative studies of somatostatin-14 and some of its fragments on passive avoidance behavior, open field activity and on barrel rotation phenomenon in rats
1989
Kynurenines, neurodegeneration and Alzheimer’s disease
2010
Increased glucose metabolism and ATP level in brain tissue of Huntington’s disease transgenic mice
2008
The effects of reward and punishment contingencies on decision-making in multiple sclerosis
2006
Kynurenine metabolism in multiple sclerosis
2005
Kynurenine and probenecid inhibit pentylenetetrazol- and NMDLA-induced seizures and increase kynurenic acid concentrations in the brain
1992
UVB irradiation-induced apoptosis increased in lymphocytes of Huntington's disease patients
2001
Amino acid concentrations in cerebrospinal fluid of patients with multiple sclerosis
1997
Interferon‐β affects the tryptophan metabolism in multiple sclerosis patients
2005
The kynurenine system and immunoregulation
2011
Effect of systemic kynurenine on cortical spreading depression and its modulation by sex hormones in rat
2012
Valproate ameliorates the survival and the motor performance in a transgenic mouse model of Huntington's disease
2009
Role of Kynurenines in the Central and Peripherial Nervous Systems
2005
Huntington's disease, behavioral disturbances, and kynurenines: Preclinical findings and therapeutic perspectives
1996
Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders
2007
Molecular plasticity of primary nociceptive neurons: relations of the NGF-c-jun system to neurotomy and chronic pain
2003
Nonenzymatic antioxidants of blood in multiple sclerosis
1999
A genome-wide screen for association in Hungarian multiple sclerosis
2003
Kynurenines in the CNS: recent advances and new questions
2012
Evaluating biomarkers of neuronal degeneration and neuroinflammation in CSF of patients with multiple sclerosis–osteopontin as a potential marker of clinical severity
2013
The role of kynurenines in disorders of the central nervous system: Possibilities for neuroprotection
2009
Peripheral and central alterations of pituitary adenylate cyclase activating polypeptide-like immunoreactivity in the rat in response to activation of the trigeminovascular system
2012
CGRP and adrenomedullin receptor populations in human cerebral arteries: in vitro pharmacological and molecular investigations in different artery sizes
2000
Intracerebroventricular injection of kynurenic acid, but not kynurenine, induces ataxia and stereotyped behavior in rats
1990
Decreased expression of kynurenine aminotransferase-I (KAT-I) in the substantia nigra of mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment
2004
Kynurenines and intestinal neurotransmission: the role of N-methyl-d-aspartate receptors
2011
Brain and CSF somatostatin concentrations in patients with psychiatric or neurological illness An overview
1988
Kynurenines in Parkinson’s disease: therapeutic perspectives
2011
The potential role of kynurenines in Alzheimer’s disease: pathomechanism and therapeutic possibilities by influencing the glutamate receptors
2013
Influence of kynurenine treatment on open-field activity, elevated plus-maze, avoidance behaviors and seizures in rats
1990
Effect of 6-hydroxydopamine treatment on kynurenine aminotransferase-I (KAT-I) immunoreactivity of neurons and glial cells in the rat substantia nigra
2006
The inimitable kynurenic acid: The roles of different ionotropic receptors in the action of kynurenic acid at a spinal level
2015
Nitroglycerin-Induced nNOS Increase in Rat Trigeminal Nucleus Caudalis is Inhibited by Systemic Administration of Lysine Acetylsalicylate but not of Sumatriptan
2004
Manipulating Kynurenic Acid Levels in the Brain – On the Edge Between Neuroprotection and Cognitive Dysfunction
2012
2008
Neurotoxins and neurodegenerative disorders.
1998
Effect of a serotonin agonist (sumatriptan) on the peptidergic innervation of the rat cerebral dura mater and on the expression of c-fos in the caudal trigeminal nucleus in an experimental migraine model
1997
Alterations in PACAP-38-like immunoreactivity in the plasma during ictal and interictal periods of migraine patients
2013
Manipulating Kynurenic Acid Levels in the Brain – On the Edge Between Neuroprotection and Cognitive Dysfunction
2012
▼Natalizumab for multiple sclerosis?
2008
Alzheimer’s Disease: Recent Concepts on the Relation of Mitochondrial Disturbances, Excitotoxicity, Neuroinflammation, and Kynurenines
2018
Unexpected effects of peripherally administered kynurenic acid on cortical spreading depression and related blood–brain barrier permeability
2013
Changing the Face of Kynurenines and Neurotoxicity: Therapeutic Considerations
2015
The role of kynurenines in the pathomechanism of amyotrophic lateral sclerosis and multiple sclerosis: therapeutic implications
2012
NMDA Antagonists as Parkinson's Disease Therapy: Disseminating the Evidence
2014
Drug safety and tolerability in prophylactic migraine treatment
2015
Organ culture of the trigeminal ganglion induces enhanced expression of calcitonin gene-related peptide via activation of extracellular signal-regulated protein kinase 1/2
2010
Favorable Early Outcome of Carotid Artery Stenting Without Protection Devices
2004